You can read our Premium News Service in full if you have an Annual Subscription to the OTCToolbox website. You can read Basic News stories free of charge.
12 January 2021
Procter & Gamble (P&G) has abandoned its proposed acquisition of Billie, AFT Pharmaceuticals’ Maxigesic pain reliever has been launched in Canada as Combogesic, and Sanofi has revealed the name and chief of its proposed active pharmaceutical ingredients (API) company.
31 December 2020
Sanofi’s Allevia – containing the antihistamine fexofenadine hydrochloride – has been switched from prescription-only to general sales list (GSL) status in the UK.
2 November 2020
Sanofi Consumer Healthcare has an opportunity to reach its consumers through “cutting-edge digital platforms”, according to new worldwide head Julie Van Ongevalle, who adds that the business needs to focus on building “true hero products” and leveraging “strong consumer innovation”.
2 November 2020
Sanofi's Consumer Healthcare business reported worldwide sales down by 1.1% in the third quarter of 2020, as the voluntary recall of Zantac in the US and Canada in October 2019 continued to have an impact.
23 October 2020
Sanofi Consumer Healthcare is set to launch Enzymatica’s common cold spray, ColdZyme, under its established brands in France and Italy.
25 August 2020
Sanofi's Consumer Healthcare business reported worldwide sales down by 8.0% at constant exchange rates in the second quarter of 2020. Paul Hudson, Sanofi's chief executive officer, said the Consumer Healthcare business would take a more assertive stance in the online sector under its new worldwide h...
14 August 2020
Perrigo is boosting its presence in Eastern Europe by acquiring three OTC brands from Sanofi for an undisclosed sum.
26 June 2020
France is establishing national production of paracetamol, the European Medicines Agency (EMA) is set to take another look at ranitidine, and GlaxoSmithKline (GSK) Consumer Healthcare has recalled some children’s medicines.
29 May 2020
Sanofi’s Consumer Healthcare business will have a new worldwide head from 1 September 2020.
28 April 2020
Sanofi's Consumer Healthcare business reported worldwide sales up by 4.2% at constant exchange rates in the first quarter of 2020. Paul Hudson, Sanofi's chief executive officer, said consumer stocking associated with the COVID-19 pandemic had contributed around six percentage points of growth.